🇺🇸
HONG KONG, Sept. 7, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces that, the ordinary shares of the Company (the “Shares”), which trade on The Stock Exchange of Hong Kong Limited (the “HK Stock Exchange”), have been included in the list of eligible securities…
Source: prnewswire
Country: United States